Company Directory

Global biopharma with UK manufacturing, commercial and clinical operations

MSD is a global biopharmaceutical company discovering, developing, manufacturing and marketing medicines and vaccines across oncology, infectious disease, immunology, cardiometabolic disease and animal health. Its UK operations span pharmaceutical manufacturing at Cramlington, Northumberland, which supplies medicines into the Merck global network, alongside commercial and clinical development functions headquartered at Moorgate, London, and an Animal Health division based in Milton Keynes. MSD conducts approximately 150 clinical studies in the UK annually.

Global pharma company in immunology, vaccines, and oncology

GSK is a multinational biopharmaceutical company engaged in the research, development, manufacture, and commercialisation of medicines and vaccines. Its pipeline and portfolio span respiratory and immunology, oncology, HIV (through its specialist subsidiary ViiV Healthcare), and infectious diseases including vaccines. The company operates major UK sites including its global R&D hub at Stevenage Bioscience Catalyst, manufacturing facilities at Barnard Castle, Ware, and Montrose, and its global headquarters in London's Knowledge Quarter.

Clinical-stage antifungal drug developer targeting invasive fungal infections

F2G is a clinical-stage biopharmaceutical company developing novel antifungal therapies for life-threatening invasive fungal infections. The company discovered the orotomides, a new class of antifungal agents that selectively inhibit fungal dihydroorotate dehydrogenase, a mechanism of action distinct from all approved antifungals. Its lead compound, olorofim, is an oral agent in Phase 3 development for invasive aspergillosis and has received FDA Breakthrough Therapy Designation for multiple indications.

High-sensitivity lateral flow diagnostics for point-of-care testing

SwiftDx is a Cambridge-based diagnostics company developing a next generation of high-sensitivity lateral flow assays using proprietary eAMP (enhanced Amplification) and DNA detection technologies. Its platform enables detection of targets undetectable by conventional lateral flow tests, without requiring specialist equipment or laboratory facilities. The company's first commercial product is a rapid mycoplasma contamination detection kit for cell culture applications. Further products in development target HIV, dengue fever, hepatitis C, and prostate cancer.

Polymer-embedded antimicrobial technology for infection prevention in medical devices

Zonova is a biotech company developing patented antimicrobial technology embedded into medical device polymers at the manufacturing stage. The technology creates a protective surface that continuously kills a broad spectrum of pathogens, including drug-resistant strains such as MRSA. Applications span catheters, cannulas, endotracheal tubes, and surgical sutures. Zonova's commercial model is B2B licensing to medical device manufacturers, within a One Health approach to tackling antimicrobial resistance.

Multiplex qPCR and NGS kits for molecular detection

YouSeq is a UK manufacturer of multiplex Next Generation Sequencing and qPCR kits, panels and reagents. The company offers one of the largest menus of qPCR targets available, covering human infectious diseases, antimicrobial resistance profiling, food and water safety, microbiome analysis, and veterinary diagnostics. Products are supplied as complete, ready-to-use kits compatible with standard laboratory platforms, serving clinical, research, and diagnostic laboratory customers.

Infectious disease antigens and antibodies for diagnostics and research

The Native Antigen Company is a manufacturer of native and recombinant antigens, antibodies, and immunoassays for viral and bacterial infectious disease targets. Products are supplied to IVD manufacturers, pharmaceutical companies, and academic institutions for use in immunoassay development, serology, vaccine research, and quality control. Contract services include custom antigen manufacture, antibody generation, and assay development using a proprietary mammalian cell expression system for native-like protein production.

Human biospecimen and disease-state plasma supplier

Logical Biological is a UK supplier of human biological materials including disease-state and normal-donor serum, plasma, swabs, tissues, PBMCs, and biofluids to IVD manufacturers and life science researchers worldwide. The company sources specimens through a global network of donor centres and blood banks across five continents, and provides customised materials including bulk engineered disease-state plasma, with capabilities in protein purification and sample processing. Customers include diagnostic test developers and IVD control manufacturers.

In vitro diagnostic reagents, test kits and analysers for clinical laboratories

Fortress Diagnostics is a Northern Ireland-based manufacturer of in vitro diagnostic products, supplying clinical chemistry reagents, immunoassays, haematology reagents, haemostasis consumables, serology test kits, quality controls and calibrators, and diagnostic instrumentation to hospitals, blood banks, and research institutions across more than 100 countries. Operating from an ISO 13485-accredited facility at Antrim Technology Park, the company distributes through an established global network spanning five continents.

BBSRC-funded national institute for animal biosciences research

The Roslin Institute is a BBSRC-funded national institute for animal biosciences research, part of the University of Edinburgh's Royal (Dick) School of Veterinary Studies. Research is organised around three challenge areas: sustainable farmed animal production, infectious disease detection and prevention, and translational animal and human health. The Institute has a strong track record in translational spinout activity, including RoslinCT and Roslin Technologies, and has pioneered gene editing applications in livestock

Infectious disease drug development and partnering organisation

Infex Therapeutics is a clinical-stage drug development company focused on antimicrobial resistance and pandemic-priority infectious diseases, based at Alderley Park. Founded as The AMR Centre in 2016, the company acquires and co-develops novel therapeutics through in-licensing and risk-sharing partnerships with biotechs, universities and pharmaceutical companies, supporting programmes from lead optimisation to Phase 2 proof of concept. Its pipeline includes programmes targeting drug-resistant Gram-negative bacteria, respiratory infections and urinary tract infections.

Non-invasive deep lung breath sampling device for molecular research

PulmoBioMed is a medical technology company developing a handheld device for collecting exhaled breath condensate from the lower respiratory tract without contamination from the upper airway or oral cavity. The device provides uncontaminated lung-derived samples for downstream molecular analysis including proteomics, metabolomics, microbiology, and nucleic acid profiling. Applications span respiratory disease diagnosis, pulmonary biomarker discovery, antimicrobial resistance research, pharmacokinetics, and toxicology screening. A clinical configuration targets point-of-need asthma diagnosis.